Brief: Microbot Medical’S Novel LIBERTY Robotic System Continues To Be Validated With Latest U.S. Design Patent Allowance
18/11/2022 14:02
Nov 18 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL’S NOVEL LIBERTY® ROBOTIC SYSTEM CONTINUES
TO BE
VALIDATED WITH LATEST U.S. DESIGN PATENT ALLOWANCE
Source text for Eikon: ID:nGNX3v6KjB
Further company coverage: MBOT.O
Recent news on Microbot Medical
See all newsMicrobot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Microbot Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Microbot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device